These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30230965)

  • 1. Being PrEPared - Preexposure Prophylaxis and HIV Disparities.
    Goldstein RH; Streed CG; Cahill SR
    N Engl J Med; 2018 Oct; 379(14):1293-1295. PubMed ID: 30230965
    [No Abstract]   [Full Text] [Related]  

  • 2. How many MSM are taking PrEP: a service evaluation.
    Whitlock GG; Douglas A; Adesara S; McCormack S; Nwokolo N; McOwan A
    Sex Transm Infect; 2017 Nov; 93(7):529. PubMed ID: 29061697
    [No Abstract]   [Full Text] [Related]  

  • 3. Reaching High-Risk Patients for HIV Preexposure Prophylaxis.
    Riddell J; Cohn JA
    JAMA; 2016 Jul; 316(2):211-2. PubMed ID: 27404188
    [No Abstract]   [Full Text] [Related]  

  • 4. Preexposure Prophylaxis for the Prevention of HIV Infection: Recommendation Statement.
    Am Fam Physician; 2019 Nov; 100(10):Online. PubMed ID: 31730317
    [No Abstract]   [Full Text] [Related]  

  • 5. Preexposure prophylaxis is effective on a national level, but is it enough.
    Kojima N; Klausner JD
    AIDS; 2021 Mar; 35(4):691-692. PubMed ID: 33620874
    [No Abstract]   [Full Text] [Related]  

  • 6. A shot at equity? Addressing disparities among Black MSM in the coming era of long-acting injectable preexposure prophylaxis.
    Goedel WC; Nunn AS; Chan PA; Duncan DT; Biello KB; Safren SA; Marshall BDL
    AIDS; 2019 Nov; 33(13):2110-2112. PubMed ID: 31577579
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk Compensation and Clinical Decision Making - The Case of HIV Preexposure Prophylaxis.
    Marcus JL; Katz KA; Krakower DS; Calabrese SK
    N Engl J Med; 2019 Feb; 380(6):510-512. PubMed ID: 30726699
    [No Abstract]   [Full Text] [Related]  

  • 8. Preexposure Prophylaxis with Tenofovir/Emtricitabine Prevents HIV Infection In Men who Have Unprotected Anal Intercourse.
    Ebell MH
    Am Fam Physician; 2016 Mar; 93(6):520. PubMed ID: 26977839
    [No Abstract]   [Full Text] [Related]  

  • 9. Time to Make the Jump: Translating HIV Pre-exposure Prophylaxis Research Into Real-World Public Health Impact.
    Patel RR; Chan PA; Mena L; Crowley JS; McCoy K; Nunn A
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):e144-e146. PubMed ID: 28379864
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV preexposure prophylaxis in the real world.
    Daskalakis DC
    Top Antivir Med; 2014; 22(4):670-5. PubMed ID: 25398067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at two United States medical centers.
    Seidman DL; Weber S; Timoney MT; Oza KK; Mullins E; Cohan DL; Wright RL
    Am J Obstet Gynecol; 2016 Nov; 215(5):632.e1-632.e7. PubMed ID: 27448959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in HIV Preexposure Prophylaxis Prescribing in the United States, 2012-2018.
    Song HJ; Squires P; Wilson D; Lo-Ciganic WH; Cook RL; Park H
    JAMA; 2020 Jul; 324(4):395-397. PubMed ID: 32720996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-exposure prophylaxis protects against HIV infection in real world setting, study finds.
    Kmietowicz Z
    BMJ; 2015 Feb; 350():h1076. PubMed ID: 25716462
    [No Abstract]   [Full Text] [Related]  

  • 15. Working Toward Broad and Equitable Access to HIV Preexposure Prophylaxis.
    Marcus JL; Krakower DS
    Am J Public Health; 2019 Sep; 109(9):1160-1161. PubMed ID: 31390256
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrent bacterial sexually transmitted infections: lessons from an HIV preexposure prophylaxis trial.
    Wood BR; Guthrie BL
    AIDS; 2022 Jul; 36(8):1191-1193. PubMed ID: 35796733
    [No Abstract]   [Full Text] [Related]  

  • 17. Configuring the users of new HIV-prevention technologies: the case of HIV pre-exposure prophylaxis.
    Holt M
    Cult Health Sex; 2015; 17(4):428-39. PubMed ID: 25270549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preexposure prophylaxis: a cautionary tale.
    Desrosiers AA; Roberts AD; Simon GL
    AIDS; 2017 Sep; 31(15):2177-2178. PubMed ID: 28906283
    [No Abstract]   [Full Text] [Related]  

  • 19. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.
    Smith DK; Van Handel M; Wolitski RJ; Stryker JE; Hall HI; Prejean J; Koenig LJ; Valleroy LA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1291-5. PubMed ID: 26606148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis Failures.
    Marcus JL; Hurley LB; Nguyen DP; Silverberg MJ; Volk JE
    Clin Infect Dis; 2017 Oct; 65(10):1768-1769. PubMed ID: 29020235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.